中国真菌感染管理政策解读  

Interpretation of China′s fungal infection management policy

作　　者：冯佳佳 孔维华 林丽开 Feng Jiajia;Kong Weihua;Lin Likai(Hospital Management Institute of Wuhan University,Zhongnan Hospital of Wuhan University,Wuhan 430071,China)

机构地区：[1]武汉大学医院管理研究所/武汉大学中南医院,武汉430071

出　　处：《中华实用儿科临床杂志》2024年第1期7-9,共3页Chinese Journal of Applied Clinical Pediatrics

摘　　要：侵袭性真菌病的发病呈现上升趋势, 真菌耐药问题也逐渐引起了全球关注。2022年世界卫生组织制定了第1份真菌病原体清单, 鼓励各国提高其真菌学诊断能力, 管理真菌感染并进行监测。我国作为全球最早发布和实施遏制细菌耐药国家行动计划的国家之一, 始终高度重视包括真菌在内的微生物耐药控制问题和抗菌药物管理, 在完善真菌病防治相关法律法规体系、加强抗真菌药物临床应用管理、提升真菌病诊疗能力和诊疗规范化水平、建立健全真菌感染及耐药监测和评估体系等方面开展了一系列工作, 取得了阶段性成效。未来, 我国在新一轮遏制微生物耐药国家行动计划的指引下, 将进一步提高真菌病诊疗水平, 减少真菌病的发生及真菌耐药性的传播。Fungal infections are a growing public health threat,especially as the at-risk population for invasive fungal disease expanding and antifungal resistance emerging.In 2022,the World Health Organization released the first fungal priority pathogens list,aiming to encourage countries to strengthen the response to fungal infections.As one of the first countries to issue and implement the National Action Plan to Contain Antimicrobial Resistance in the world,China has attached great importance to the management of fungal infections.A series of actions and efforts have been made,including improving the legal and regulatory system related to the prevention and treatment of fungal infections,strengthening the management of clinical application of antifungal drugs,improving the diagnosis and treatment ability of fungal infections and the standardization of diagnosis and treatment,establishing a monitoring and evaluation system for fungal infections and drug resistance.Initial results have been achieved.In the future,under the guidance of the new national action plan to contain antimicrobial resistance,the level of diagnosis and treatment of fungal infections will be further improved to reduce the occurrence of fungal infections and the spread of antifungal resistance.

关 键 词：真菌感染 抗真菌药物 政策 

分 类 号：R519[医药卫生—内科学]